Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 10/20 | 0.48 |
| ▸ | FAAH | O00519 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | XDH | P47989 | 4/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6465186 | 0.91 | ALDH1A1 (0.44) | DAGLAFAAHCES1ALDH1A1XDH | |
| SCHEMBL6464421 | 0.91 | ALDH1A1 (0.44) | DAGLAFAAHCES1ALDH1A1XDH | |
| SCHEMBL6463072 | 0.85 | DAGLA (0.60) | DAGLAFAAHCES1XDH | |
| SCHEMBL6475520 | 0.82 | DAGLA (0.50) | DAGLAFAAHCES1XDHPPARG | |
| SCHEMBL6467552 | 0.81 | DAGLA (0.51) | DAGLAFAAHCES1XDHPPARG | |
| SCHEMBL6462825 | 0.79 | XDH (0.38) | FAAHCES1ALDH1A1XDHPPARG | |
| SCHEMBL6464410 | 0.77 | FAAH (0.42) | DAGLAFAAHCES1ALDH1A1 | |
| SCHEMBL7049749 | 0.77 | DAGLA (0.50) | DAGLAFAAHCES1XDHPPARG | |
| SCHEMBL6465108 | 0.77 | XDH (0.39) | FAAHCES1ALDH1A1XDH | |
| SCHEMBL7049518 | 0.76 | DAGLA (0.46) | DAGLAFAAHCES1ALDH1A1XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1516877-A1 | Amine derivatives as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-23 | — | — | EP | disclosed |